Improving the Maglev Heart Pump for Heart Failure
Maglev LVAD with expandable stented inlet and anti-thrombotic coating to improve hemocompatibility
This project develops a new type of heart pump, called a Maglev LVAD, to help people with severe heart failure live longer and healthier lives.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas Heart Institute NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11110455 on NIH RePORTER |
What this research studies
Heart failure affects millions, and while Left Ventricular Assist Devices (LVADs) are a good option for many, complications like bleeding and blood clots are a concern. This project is creating an improved Maglev LVAD, which is a special heart pump that uses magnetic forces to help the heart. Researchers are designing it with a new inlet and a special coating to make it more compatible with blood, aiming to significantly reduce the risk of these serious complications. The goal is to make LVADs a safer and more effective treatment for those with advanced heart failure.
Who could benefit from this research
Good fit: Patients with end-stage heart failure who are candidates for a Left Ventricular Assist Device (LVAD) would be the primary beneficiaries of this technology.
Not a fit: Patients with heart conditions that do not require an LVAD or those who are not candidates for such a device would not directly benefit from this specific innovation.
Why it matters
Potential benefit: If successful, this improved heart pump could significantly reduce life-threatening complications like bleeding and blood clots for patients with severe heart failure.
How similar studies have performed: While LVADs are already in use, this project introduces innovative design and coating technologies to specifically address existing complications, building upon prior advancements in device development.
Where this research is happening
Houston, United States
- Texas Heart Institute — Houston, United States (Active)
Researchers
- Principal investigator: Frazier, O. H. — Texas Heart Institute
- Study coordinator: Frazier, O. H.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.